Transgenic goats that produce monoclonal antibodies for anti-cancer therapy recently were developed by scientists from AgResearch in New Zealand. With further research the goats may prove to produce large volumes of an antibody through their milk without the expensive production costs of the same antibody in laboratory-controlled environments, according to the research organization.





